Capital Analysts, LLC Novartis Ag Transaction History

Capital Analysts, LLC

$2.45 Billion
Q3 2024

A detailed history of Capital Analysts, LLC transactions in Novartis Ag stock. As of the latest transaction made, Capital Analysts, LLC holds 5,083 shares of NVS stock, worth $499,913. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,083

Previous 4,520 12.46%

Holding current value

$499,913

Previous $481,000 21.62%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $59,751 - $68,061	563 Added 12.46%	5,083 $585,000
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $20,087 - $23,299	217 Added 5.04%	4,520 $481,000
Q4 2023 Jan 30, 2024	SELL	$92.27 - $101.54 $119,489 - $131,494	-1,295 Reduced 23.13%	4,303 $434,000
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $852 - $946	9 Added 0.16%	5,598 $570,000
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $118,980 - $134,914	1,286 Added 29.89%	5,589 $564,000
Q4 2022 Feb 08, 2023	SELL	$75.55 - $92.52 $906 - $1,110	-12 Reduced 0.28%	4,303 $390,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $4,476 - $5,235	-60 Reduced 1.37%	4,315 $328,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $4,831 - $5,625	-60 Reduced 1.35%	4,375 $370,000
Q1 2022 May 12, 2022	SELL	$80.11 - $90.62 $801 - $906	-10 Reduced 0.22%	4,435 $389,000
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $4,782 - $5,287	-60 Reduced 1.33%	4,445 $389,000
Q3 2021 Nov 04, 2021	SELL	$81.78 - $95.14 $1,962 - $2,283	-24 Reduced 0.53%	4,505 $369,000
Q2 2021 Nov 15, 2021	SELL	$85.24 - $94.15 $113,880 - $125,784	-1,336 Reduced 22.78%	4,529 $413,000
Q2 2021 Aug 05, 2021	BUY	$85.24 - $94.15 $119,591 - $132,092	1,403 Added 31.44%	5,865 $535,000
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $370,239 - $436,615	4,434 Added 15835.71%	4,462 $381,000
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $2,185 - $2,644	28 New	28 $3,000
Q2 2020 Aug 07, 2020	SELL	$80.93 - $91.1 $44,754 - $50,378	-553 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$84.35 - $95.37 $43,777 - $49,497	-519 Reduced 48.41%	553 $52,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $30,879 - $34,027	-361 Reduced 25.19%	1,072 $93,000
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $6,409 - $7,888	85 Added 6.31%	1,433 $131,000
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $15,063 - $17,230	-200 Reduced 12.92%	1,348 $129,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $31,305 - $34,858	-425 Reduced 21.54%	1,548 $133,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $25,387 - $27,251	351 Added 21.64%	1,973 $166,000
Q4 2017 Feb 12, 2018	SELL	$72.33 - $77.64 $25,387 - $27,251	-351 Reduced 17.79%	1,622 $93,000
Q3 2017 Nov 06, 2017	BUY	$74.14 - $77.27 $146,278 - $152,453	1,973	1,973 $169,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Account

Capital Analysts, LLC Novartis Ag Transaction History